Figure 1.

Percentages of patients with anastomotic dehiscence, surgical wound dehiscence and sternal dehiscence by time between discontinuation of anti-fibrotic medication and transplant.

Shorter: discontinued anti-fibrotic medication ⩽ 5 medication half-lives before transplant; longer: discontinued anti-fibrotic medication > 5 medication half-lives before transplant.